Zobrazeno 1 - 10
of 85
pro vyhledávání: '"Mengyang Di"'
Autor:
Nikolai A. Podoltsev, Rong Wang, Rory M. Shallis, Jessica M. Stempel, Mengyang Di, Natalia Neparidze, Amer M. Zeidan, Scott F. Huntington, Smith Giri, Sarah C. Hull, Steven D. Gore, Xiaomei Ma
Publikováno v:
Cancer Medicine, Vol 12, Iss 18, Pp 18889-18900 (2023)
Abstract Background Polycythemia vera (PV) and essential thrombocythemia (ET) are linked to increased risk of cardiovascular morbidity and mortality. In addition to the reduction in of arterial thrombotic events, statins may prevent venous thrombosis
Externí odkaz:
https://doaj.org/article/37b984a3a27e4915a681f12f7319c9f7
Autor:
Mengyang Di, Jessica B. Long, Shalin K. Kothari, Tarsheen Sethi, Amer M. Zeidan, Nikolai A. Podoltsev, Rory M. Shallis, Rong Wang, Xiaomei Ma, Scott F. Huntington
Publikováno v:
Haematologica, Vol 108, Iss 8 (2023)
Externí odkaz:
https://doaj.org/article/607f573d727649d79cca4c4021593458
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 8, Iss , Pp 100202- (2022)
Summary: Immune checkpoint inhibitors are an emerging therapy for metastatic sarcomas that have failed conventional therapies such as methotrexate, doxorubicin, and cisplatin. Much is still not known about the toxicities that these treatments would c
Externí odkaz:
https://doaj.org/article/b6027593ebce49d7a35fde6e27dbf3ee
Autor:
Kunal C. Potnis, Mengyang Di, Iris Isufi, Lohith Gowda, Stuart E. Seropian, Francine M. Foss, Howard P. Forman, Scott F. Huntington
Publikováno v:
Blood Advances. 7:801-810
Follicular lymphoma (FL) is traditionally considered treatable but incurable. In March 2021, the US Food and Drug Administration approved the use of chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed or refractory (R/R) FL after
Autor:
Michel Jadoul, Marina C. Berenguer, Wahid Doss, Fabrizio Fabrizi, Jacques Izopet, Vivekanand Jha, Nassim Kamar, Bertram L. Kasiske, Ching-Lung Lai, Jose´ M. Morales, Priti R. Patel, Stanislas Pol, Marcelo O. Silva, Ethan M. Balk, Craig E. Gordon, Amy Earley, Mengyang Di, Paul Martin
Publikováno v:
Počki, Vol 7, Iss 4, Pp 261-268 (2018)
No abstract
Externí odkaz:
https://doaj.org/article/3cdec82a2f454c6687b2921cafea2d3f
Autor:
Gaelen P. Adam, Mengyang Di, Susan Cu-Uvin, Christopher Halladay, Bryant T. Smith, Suchitra Iyer, Thomas A. Trikalinos
Publikováno v:
Systematic Reviews, Vol 7, Iss 1, Pp 1-10 (2018)
Abstract Background While in its early years the HIV epidemic affected primarily the male and the young, nowadays, the population living with HIV/AIDS is approximately 24% women, and its age composition has shifted towards older ages. Many of the old
Externí odkaz:
https://doaj.org/article/25ccfa8745f948fe9541fe5332b5e0ac
Autor:
Rory Michael Shallis, Rong Wang, Amer M. Zeidan, Scott F Huntington, Natalia Neparidze, Jessica M Stempel, Lourdes M Mendez, Mengyang Di, Xiaomei Ma, Nikolai A. Podoltsev
Publikováno v:
Blood Advances.
Tyrosine kinase inhibitor (TKI) use is critical to the care of patients with chronic myeloid leukemia (CML). Quantitative BCR-ABL1 polymerase chain reaction (qPCR) testing every 3 months during the first year of TKI treatment is recommended to assure
Autor:
Mengyang Di, Tamra Keeney, Emmanuelle Belanger, Scott F. Huntington, Adam J. Olszewski, Orestis A. Panagiotou
Publikováno v:
Journal of the American Geriatrics Society.
Autor:
Mengyang Di, Jessica B Long, Shalin K. Kothari, Tarsheen Sethi, Amer M. Zeidan, Nikolai A. Podoltsev, Rory Michael Shallis, Rong Wang, Jessica M. Stempel, Xiaomei Ma, Scott F. Huntington
Publikováno v:
Blood. 140:10904-10906
Publikováno v:
JCO Oncol Pract
PURPOSE: To examine the impact of global risk, a measure comprising age, comorbidities, function, and cognitive statuses, on treatment selection and outcomes among older home care recipients with diffuse large B-cell lymphoma. METHODS: From SEER-Medi